@misc{indiciae3a3de803d0a2,
  title = {Randomized phase 2 trial of CPX-351 vs. CLAG-M (cladribine, cytarabine, G-CSF, and mitoxantrone) for medically unfit adults with acute myeloid leukemia or other high-grade myeloid neoplasms.},
  author = {Anna B Halpern and Megan Othus and Mary-Elizabeth M Percival and Cristina Ghiuzeli and Jacob S Appelbaum and Paul C Hendrie and Ryan D Cassaday and Max Smith and Kathryn Russell and Bart L Scott and Jason P Cooper and Joshua R Veatch and Siob\&\#xe1;n B Keel and Vivian G Oehler and Erik L Kimble and Raya Mawad and Roland B Walter},
  year = {2026},
  doi = {10.1038/s41375-026-03044-8},
  url = {https://pubmed.ncbi.nlm.nih.gov/42443407/},
  note = {Source identifier: 42443407}
}